[Direct answer]In the Beijing area, before participating in a clinical drug trial, it is a statutory right of the subject to sign an informed consent form in accordance with the law. According to Article 108 of the Civil Code of the People's Republic of China (effective January 1, 2021), clinical trials should obtain the written consent of the subject or his/her guardian; the "Quality Management Guidelines for Clinical Drug Trials" (effective July 1, 2020) further require informing the subject of the purpose, methods, risks, benefits, alternative options, and the right to withdraw voluntarily, and having the subject sign and confirm them. Informed consent is not a "liability waiver"; institutions are not allowed to waive legal responsibilities by signing it. Before signing, the subject should fully understand the content and have the right to withdraw at any time without giving any reason. It is recommended to check each item before signing, keep a copy, and consult a professional lawyer if necessary. For more details, please refer toLegal services for personal injury and medical disputes.

1. Problem background and typical scenarios

The controversy over informed consent often arises in clinical trials of innovative drugs for tumors and rare diseases. Typical scenarios include: institutions refusing to provide a complete risk description on the grounds of "project confidentiality" and only requiring subjects to sign the consent form; using professional jargon to make it difficult for patients to understand, with the formality of signing the consent form failing to reflect actual informed consent; drafting the informed consent form as a broad waiver of liability, claiming that "all consequences will be borne by the signatory"; and changing the trial protocol without re-obtaining consent. Many subjects, eager to seek medical treatment, hastily sign the consent form only to realize later that their rights have been infringed. Informed consent is a dynamic process rather than a mere document, and it should be implemented throughout the entire trial. For other medical research, relevant provisions can be referenced accordingly.Special services and other case servicesAnalysis and judgment.

II. Key points of dispute

There are three main points of contention. Firstly, the adequacy of information disclosure: whether the risks, benefits, alternative options, and withdrawal rights are explained in understandable language, rather than just going through the signature process. Secondly, the authenticity of consent: whether the subjects signed the consent form voluntarily without coercion and with balanced information, and whether the institution has obtained ethical approval. Thirdly, changes and re-consent: whether the subjects are informed and obtain consent again when there are significant changes to the trial protocol or risks. In practice, institutions often use the "already signed" defense to evade responsibility, but signing the form does not exempt them from their legal obligations to provide information and exercise caution. Defects in the disclosure of information itself can constitute negligence.

III. Professional analysis by Hengluo Lawyers

Based on practical observations in handling clinical trial disputes, subjects are most likely to fall into the cognitive misconception that "signing the document means waiving liability". Many institutions draft informed consent forms as liability exemption documents, misleading subjects into giving up their rights; some subjects fail to keep copies and cannot prove the content of the informed consent afterwards. Henglu Lawyers usually advise: before signing, read the risk and withdrawal clauses item by item, request explanations and records for unclear terms, and keep a copy of the signed document; if there are changes to the trial protocol, subjects should be required to give their consent again. For issues involving trial contracts and the protection of subjects' rights, legal assistance can be sought.Business and contract dispute resolution services for enterprisesClarify rights and obligations.

IV. Practical suggestions and legal basis

The legal basis includes Article 108 of the Civil Code of the People's Republic of China (effective from January 1, 2021) (clinical trials must obtain written consent and cannot charge fees); the provisions on the protection of subjects' rights in the Pharmaceutical Administration Law of the People's Republic of China (effective from December 1, 2019); the detailed requirements on informed consent, the obligation to provide information, and ethical review in the Guidelines for Quality Management of Drug Clinical Trials (effective from July 1, 2020); and the Regulations on the Prevention and Handling of Medical Disputes (effective from October 1, 2018). Practical suggestions: Read all provisions before signing, keep a copy for yourself, re-agree to any changes, and keep records of communication; if your rights are infringed, you can claim compensation according to law. For cases involving medical harm and other claims, you can combine them together.Personal injury and medical dispute servicesCoordinate and plan things in an organized and efficient way to achieve the best results.

5. Henglu Law Firm's Advice

Informed consent is a "protective shield" for subjects, not an "exemption clause" for institutions. Before signing, it is essential to understand the risks, benefits, and rights to withdraw. Require explanations for ambiguous terms and keep records of the discussions; never sign blank documents or those with only exemption clauses. After signing, subjects can withdraw at any time without reason and without being discriminated against. Institutions are not allowed to coerce subjects into withdrawing as a form of retaliation. Keeping a copy of the informed consent form in their files is the basis for protecting their rights in the future. Do not believe the claim that "once you sign, you can't claim compensation". Legal responsibilities are not exempted by signing. When in doubt, it is recommended to consult a professional lawyer to confirm their rights in advance.

VI. Frequently Asked Questions

Q1: If I don't sign the informed consent form, can the institution let me participate in the experiment directly?

No. According to Article 108 of the Civil Code and the GCP, clinical trials must obtain the written consent of the subjects, and cannot be conducted without their consent. The review by the ethics committee is also a statutory preliminary procedure. If the institution conducts the trial without informing or obtaining the consent of the subjects, it is not only a violation of regulations, but also should bear tort liability if it causes any damage. Even if the trial has therapeutic exploration value, it cannot bypass the consent process by claiming that "it's for the patients' own good". If there is forced or implied consent to participate in the trial, the subjects can refuse and file a complaint. When there are doubts about the subjects' rights and interests, they can seek legal advice or file a lawsuit.Special services and other case servicesEvaluate the relief efforts.

Q2: Before signing the informed consent form, what information should I verify in detail?

Key verification items include: whether the purpose and methods of the trial are clearly described; whether known risks and discomforts are listed; whether the expected benefits and alternative treatments are explained; the right to voluntarily withdraw from the trial and the consequences of withdrawal; privacy and data processing; compensation for damages or insurance arrangements; contact information; and whether the trial has undergone ethical review. Ensure that you understand the content under conditions of informed consent and without coercion. Require simple explanations of professional terms and record them; blank items must be filled in. After signing, keep a complete copy for future reference when exercising rights and seeking legal protection.

Q3: After signing the informed consent form, does it still cost a lot of money to protect one's rights?

If there is damage due to the disclosure of defects or errors in the trial, the applicant can first claim compensation or insurance payments from the sponsor in accordance with GCP, which does not necessarily entail high costs. For litigation, the litigation costs shall be calculated in accordance with the "Method for Payment of Litigation Costs" based on the amount of the claim, and the losing party shall bear the costs. The attorney's fees shall be determined in accordance with the entrustment contract. In many cases, keeping the informed consent forms and medical records can support negotiations or complaints, and litigation may not be necessary. It is recommended to keep copies during the signing stage and fix the evidence after the injury to reduce the cost of protecting rights in the future. If necessary, apply for legal aid.

Q4: How long does it usually take to resolve disputes related to informed consent?

It varies depending on the legal path. For complaints to ethics committees or regulatory authorities, the processing period depends on the procedures of the institutions and departments, which may take several weeks to months; the identification of causality often takes several weeks to months; the first-instance litigation follows the general procedure for six months and the summary procedure for three months, and the complex cases or appeals take even longer. Overall, it may take more than half a year or even a year from making a claim to reaching a conclusion. It is recommended to keep a copy when signing the agreement, fix the evidence immediately after the injury, and prioritize negotiation or complaints to shorten the processing period, and resort to litigation only when necessary.

Q5: What should I pay attention to when signing the informed consent form?

Here are four suggestions: 1. Read the purpose, risks, benefits, alternatives, and withdrawal rights of the trial in detail. If anything is unclear, request oral and written explanations. 2. Verify whether the trial has undergone ethical review and whether the institutions and sponsors meet the required qualifications. 3. Refuse to sign documents that are blank or only contain disclaimers, and ensure compensation or insurance arrangements are in place. 4. After signing, keep a complete copy and maintain communication records. If there are any changes to the trial protocol, you should request to re-consent to them. If you have any doubts, consult a lawyer immediately. For reference, you can refer to the following materials:Personal injury and medical dispute servicesObtain assistance.

The above Q&A is mainly based on the judicial practice in the Beijing area. There may be differences in the adjudication opinions in different regions. It is recommended to consult a professional lawyer based on the specific circumstances of the case.

If you are currently facing similar problems, it is recommended that you consult a professional lawyer as soon as possible with the relevant evidence, to avoid missing the statutory time limits. →Personal injury legal services·Beijing Hengluo Law Firm

Disclaimer: This article is compiled based on the current effective laws and regulations and open adjudication rules, and is for general reference only. It does not constitute a formal legal opinion on specific cases. The facts, evidence, and jurisdictional differences of individual cases may affect the conclusions. If you encounter disputes, please consult a practicing lawyer in time.